amlodipine besylate and benazepril hydrochloride

Generic: amlodipine besylate and benazepril hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name amlodipine besylate and benazepril hydrochloride
Generic Name amlodipine besylate and benazepril hydrochloride
Labeler a-s medication solutions
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

amlodipine besylate 10 mg/1, benazepril hydrochloride 20 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-6427
Product ID 50090-6427_323f987f-059b-466e-abc1-e133b0393c01
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078466
Listing Expiration 2026-12-31
Marketing Start 2018-08-01

Pharmacologic Class

Classes
angiotensin converting enzyme inhibitor [epc] angiotensin-converting enzyme inhibitors [moa] calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] decreased blood pressure [pe] dihydropyridine calcium channel blocker [epc] dihydropyridines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500906427
Hyphenated Format 50090-6427

Supplemental Identifiers

RxCUI
898342
UNII
864V2Q084H N1SN99T69T

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amlodipine besylate and benazepril hydrochloride (source: ndc)
Generic Name amlodipine besylate and benazepril hydrochloride (source: ndc)
Application Number ANDA078466 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
  • 20 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (50090-6427-0)
  • 90 CAPSULE in 1 BOTTLE (50090-6427-1)
source: ndc

Packages (2)

Ingredients (2)

amlodipine besylate (10 mg/1) benazepril hydrochloride (20 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "323f987f-059b-466e-abc1-e133b0393c01", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342"], "spl_set_id": ["c9693ad5-0fa6-4796-b20b-2021d589a132"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (50090-6427-0)", "package_ndc": "50090-6427-0", "marketing_start_date": "20230407"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (50090-6427-1)", "package_ndc": "50090-6427-1", "marketing_start_date": "20230407"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "50090-6427_323f987f-059b-466e-abc1-e133b0393c01", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "50090-6427", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA078466", "marketing_category": "ANDA", "marketing_start_date": "20180801", "listing_expiration_date": "20261231"}